Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/31/25 Corcept Therapeutics (CORT) Relacorilant for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
3/31/25 AstraZeneca (AZN) AZD0780 for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
3/31/25 Vaxcyte (PCVX) VAX-24 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
3/30/25 Eli Lilly (LLY) Lepodisiran for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
3/29/25 Novo Nordisk (NVO) Rybelsus for Cardiovascular Disease Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/26/2025 Subscribers Only Subscribers Only Trial Data - Updated Results
03/27/2025 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation
03/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation (Emerging Markets)
03/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation